.png)
GENEWIZ Multiomics & Synthesis Solutions from Azenta Life Sciences offers a wide range of predeveloped assays – your express route to cutting-edge research in oncology, neurological disorders, and more. Unlock the power of off-the-shelf assays, including key targets like BRCA1/2, TP53, HTT, and FOXP2. Collaborate with our adept scientists, submit samples via convenient drop boxes, and receive rapid results to elevate your research with precision, minus the hassle.
Various sample types accepted, including cell, tissue, FFPE, gDNA, RNA, and more
Industry-leading customer support, including weekly project updates
Data delivery starting at just 3 business days after assay development
FEATURED PREDEVELOPED ASSAYS
Please contact our Customer Support for additional genes. New assay development may require an additional 5 days.
See Full List of Assays
Filter Table
| GENE ID | Gene Name | Primary Panel | Details/Secondary Panel Opportunities |
| BRCA2 | Breast Cancer 2, Early Onset | Pan-Cancer | Hereditary Breast Cancer, solid tumors, oncology |
| HRAS | Harvey Rat Sarcoma Viral Oncogene Homolog | Pan-Cancer | HRAS signaling, MAPK signaling, oncology |
| IDH1 | Isocitrate Dehydrogenase 1 | Pan-Cancer | Cellular metabolism, oncology |
| IDH2 | Isocitrate Dehydrogenase 2 | Pan-Cancer | Cellular metabolism, oncology |
| IDH3 | Isocitrate Dehydrogenase 3 | Pan-Cancer | Cellular metabolism, oncology |
| IDH4 | Isocitrate Dehydrogenase 4 | Pan-Cancer | Cellular metabolism, oncology |
| IDH5 | Isocitrate Dehydrogenase 5 | Pan-Cancer | Cellular metabolism, oncology |
| IDH6 | Isocitrate Dehydrogenase 6 | Pan-Cancer | Cellular metabolism, oncology |
| IDH7 | Isocitrate Dehydrogenase 7 | Pan-Cancer | Cellular metabolism, oncology |
| IDH8 | Isocitrate Dehydrogenase 8 | Pan-Cancer | Cellular metabolism, oncology |
| KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
| MAP2K1 | Mitogen-Activated Protein Kinase Kinase 1 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
| MAP2K2 | Mitogen-Activated Protein Kinase Kinase 2 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
| MAPK1 | Mitogen-Activated Protein Kinase 1 | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
| NRAS | Neuroblastoma RAS Viral Oncogene Homolog | Pan-Cancer | RAS signaling, MAPK signaling, oncology |
| PIK3CA | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase | Pan-Cancer | PI3K signaling, mTor signaling, solid tumors, oncology |
| PTEN | Phosphatase and Tensin Homolog | Pan-Cancer | Tumor suppressor, solid tumors, oncology |
| p53 | Tumor Protein p53 | Pan-Cancer | Oncology |
| APOE | Apolipoprotein E | Neuropathology | Alzheimer's disease, dementia, neuropathology |
| EGFR | Epidermal Growth Factor Receptor | Pan-Cancer | Oncology, lung cancers, solid tumors |
| TNF | Tumor Necrosis Factor | Pan-Cancer | Immunology, IBD, autoimmune disorders, oncology |
| IL6 | Interleukin-6 | Auto-immune | Autoimmune disorders, arthritis |
| COL1A2 | Collagen type 1 alpha 2 chain | Pan-cancer | Tumorigenesis, oncology, connective tissue disorders |
| PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | Pan-cancer | Alzheimer's disease, dementia, neuropathy, oncology |
| USMG5 | AKA ATP5MK; ATP synthase membrane subunit k | Auto-immune | Diabetes |
| ATP13A3 | ATPase 13A3 | Pan-Cancer | Oncology, polyamine trafficking, pancreatic cancer |
| SERPINA1 | Serpin family A member 1 | Auto-immune | Liver disease |
| GJB2 | Gap junction protein beta 2 | Neuropathy | Hearing loss, neuropathy |
| TRIM62 | Tripartite motif containing 62 | Auto-immune | Innate immune response, autoimmune disorders |
| CARD9 | Caspase recruitment domain family member 9 | Auto-immune | Innate immune response, autoimmune disorders |
| JAG1 | Jagged canonical Notch ligand 1 | Pan-Cancer | Notch signaling, developmental disorders, oncology |
| BRAF | B-Raf proto-oncogene, serine/threonine kinase | Pan-Cancer | MAPK signaling, oncology |